Dynavax Technologies Corp. (DVAX) Company Profile & Statistics

Dynavax Technologies Corp.
DVAX
(Nasdaq - US)
N/A
11.74
+0.02 (+0.13%)
in:usd•As of: May 03, 2024 15:59 UTC -4
Open
11.79
High
12.06
Low
11.73

About Dynavax Technologies Corp.

CEO

Ryan Spencer

Headquarters

2100 powell street, suite 720

emeryville, ca 94608, united states

Auditor

Ernst & Young LLP

Employees

408

Share Holders

Website

www.dynavax.com

Industry

biotechnology

Sector

health technology

Company Overview

Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.

Dynavax Technologies Corp. Statistics

Valuation Measures

Market Capitalization ²	1.54B
Enterprise Value	1.64B
Enterprise Value/EBITDA (ttm)	-35.37
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	2.44
Price to Sales (ttm)	6.61
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	77.88%
Operating Margin (ttm)	-2.75%
Profit Margin (ttm)	-6.30%
Return on Equity (ttm)	-1.08%
Return on Invested Capital (ttm)	-0.92%
Return on Assets (ttm)	-0.66%

Income Statement

Revenue (ttm)	232.28M
Revenue Per Share (ttm)	1.78
Gross Profit (ttm)	182.12M
EBITDA (ttm)³	-46.31M
Net Income Avi to Common (ttm)	-6.39M
Diluted EPS (ttm)	-0.06

Share Statistics

Beta (5Y Monthly)	1.30
52-Week Change	4.13%
S&P500 52-Week Change	26.43%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	130.61M
Dividend Yield	0.00%
Float ⁴	126.96M
% Held by Insiders	2.98%
% Held by Institutions	96.96%

Balance Sheet

Total Cash (mrq)	742.30M
Total Cash Per Share (mrq)	5.68
Total Debt (mrq)	252.42M
Total Debt/Equity (mrq)	40.58%
Current Ratio (mrq)	13.81%
Quick Ratio (mrq)	12.96%
Book Value Per Share (mrq)	4.80

Cash Flow

Operating Cash Flow Per Share (ytd)	0.78
Free Cash Flow (ytd)	97.46M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Dynavax Technologies Corp.

Trade With A Regulated Broker